dialysis
Thousands of kidney disease patients set to benefit from £1-a-dose diabetes drug which can reduce the need for dialysis and a transplant
Business
Robert Johnson
Empagliflozin slows kidney disease which can affect one in ten people The drug will be made available to more than 220,000 people ...
